Clinical Trials Directory

Trials / Completed

CompletedNCT02784197

cPSTA System CADLAD Study

Cardiac Phase Space Tomography Analysis (cPSTA) System: Coronary Artery Disease Learning and Development Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,622 (actual)
Sponsor
Analytics For Life · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study is primarily designed to collect resting phase signals from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography to machine learn and test an algorithm for detecting the presence of significant coronary artery disease in symptomatic adult patient.

Detailed description

This clinical protocol is primarily designed to collect resting phase signals from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography to machine learn and test an algorithm for detecting the presence of significant coronary artery disease in symptomatic adult patient. In addition to this primary objective, machine-learned algorithms will be developed and tested to report the left ventricular ejection fraction and to identify the location of significant coronary artery disease. The performance of the machine-learned algorithm will be evaluated using a comparative paired trial design. In this study, the physician will not be provided the results of analysis performed and, accordingly, the results of the analyses will not be used to guide treatment decisions for the patient.

Conditions

Interventions

TypeNameDescription
DEVICEPhase Signal RecorderThe cPSTA System is a medical device system that uses passive tomography to analyze a patient's phase space data to identify the presence of significant coronary artery disease. The cPSTA System consists of several components that work together to obtain, transmit, analyze the data, and display the results, including the Phase Signal Acquisition System (PSAQ System), which is the Phase Signal Recorder (PSR) and the Phase Signal Data Repository (PSDR); analytical software; and secure web portal. For this study only the PSAQ System is used by the clinical site for the purposes of acquiring and transmitting the signal.

Timeline

Start date
2016-05-01
Primary completion
2017-12-01
Completion
2018-05-01
First posted
2016-05-27
Last updated
2019-06-12

Source: ClinicalTrials.gov record NCT02784197. Inclusion in this directory is not an endorsement.